Optimapharm Announces Conferences Attendance in Q4 of 2022
Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce its attendance at conferences in Q4 of 2022.
BIO-Europe has a long track record of being the hub of innovation in the biotech, pharma, and financial sectors. Hosted in a different city each year the event has built a strong network of medical professionals from over 60 countries. BIO-Europe continues to foster knowledge transfer and innovation through its annual fair trade editions in Europe thus making it the most progressive science cluster on the continent.
Optimapharm’s CEO – Ivana Waller, Senior Clinical Operations Director – Gábor Szamosközi, Vice President of Marketing and Sales – Marie Dominique Garchon, and Business Development Director – Sara Babić are attending the BIO Europe conference, 24-26th October, 20222 in Leipzig, Germany. To meet our team and discuss how Optimapharm can support your clinical study visit our booth #74.
This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. Combining our OCT, CTS, and Medical Devices events, this is the perfect platform for professionals from across a range of clinical trial functions to meet, network, and hear about the latest developments.
Optimapharm’s Clinical Operations Director – Stiina Vuorio, Business Development Director – Timothy Sirard, and Business Development Director – Poppy Gratton are attending the OUTSOURCING IN CLINICAL TRIALS & CLINICAL TRIAL SUPPLY NORDICS 2022 conference, 25-26th October, 20222 in Copenhagen, Denmark. To meet our team and discuss how Optimapharm can support your clinical study visit our booth #22.
Clinical Trials Europe is a conference dedicated to streamlining clinical trials and improving patient outcomes through partnerships, outsourcing, operations & technology.
Topic: STEP INTO THE NEW ERA OF CLINICAL TRIALS: FUTURE-PROOF YOUR STRATEGIES TO ENSURE CLINICAL TRIAL SUCCESS
Decentralized Trials, Digital Health, Patient Centricity, Real World Evidence, Diversity and Sustainability and Post-Pandemic Learnings
Optimapharm’s Vice President Clinical Operations – Ana Stojković, Senior Clinical Operations Director – Lidia Almirall, Vice President Marketing and Sales – Marie Dominique Garchon, Business Development Director – Sara Babić, and Business Development Director – Poppy Gratton are attending Clinical Trials Europe 2022 conference, 7-9 October, 20222 in Amsterdam, The Netherlands. To meet our team and discuss how Optimapharm can support your clinical study visit our booth #21.
Outsourcing in Clinical Trials DACH event will be returning to Munich on 30th November and 1st December 2022. This event will focus on the operational challenges in clinical development found within Germany, Austria, and Switzerland. Over 2 days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivizing good relationships with CROs, and constructing defined deadlines.
Optimapharm’s Clinical Operations Director – Zachary Birovljev, and Vice President of Marketing and Sales – Marie Dominique Garchon, are attending OCT DACH 2022 conference, 31st November – 1st December, 20222 in Münich, Germany. To meet our team and discuss how Optimapharm can support your clinical study visit our booth #10.
